Literature DB >> 17697639

IL-13 receptor isoforms: breaking through the complexity.

Yasuhiro Tabata1, Gurjit K Khurana Hershey.   

Abstract

Interleukin (IL)-13 is an immunoregulatory cytokine secreted predominantly by activated T-helper type 2 (Th2) cells, and it has been identified as crucial in developing allergic inflammatory responses. Its diverse functions are mediated by a complex receptor system including IL-4 receptor alpha (IL-4Ralpha; CD124) and two other cognate cell surface proteins, IL-13Ralpha1 (CD213a1) and IL-13Ralpha2 (CD213a2). IL-13Ralpha1 forms a heterodimer with IL-4Ralpha that is a signaling IL-13 receptor. In contrast, IL-13Ralpha2 has been thought to be a decoy receptor due to its short cytoplasmic tail. IL-13Ralpha2 exists on the cell membrane, intracellularly, and in soluble form. Recent reports revealed that membrane IL-13Ralpha2 may have some signaling capabilities, and soluble IL-13Ralpha2 is a critical endogenous modulator for IL-13 responses. The receptor has more complicated functions than a simple decoy receptor. In this review, we describe the isoforms of IL-13Ralpha2 and discuss newly revealed functions of IL-13Ralpha2.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17697639     DOI: 10.1007/s11882-007-0051-x

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  55 in total

1.  Allergy-driven alternative splicing of IL-13 receptor alpha2 yields distinct membrane and soluble forms.

Authors:  Yasuhiro Tabata; Weiguo Chen; Manoj R Warrier; Aaron M Gibson; Michael O Daines; Gurjit K Khurana Hershey
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

2.  Level of expression of IL-13R alpha 2 impacts receptor distribution and IL-13 signaling.

Authors:  Michael O Daines; Yasuhiro Tabata; Bradley A Walker; Weiguo Chen; Manoj R Warrier; Saswata Basu; Gurjit K Khurana Hershey
Journal:  J Immunol       Date:  2006-06-15       Impact factor: 5.422

3.  Chromosome mapping and expression of the human interleukin-13 receptor.

Authors:  J Guo; F Apiou; M P Mellerin; B Lebeau; Y Jacques; S Minvielle
Journal:  Genomics       Date:  1997-05-15       Impact factor: 5.736

4.  Reconstitution of a functional human type II IL-4/IL-13 receptor in mouse B cells: demonstration of species specificity.

Authors:  R Andrews; L Rosa; M Daines; G Khurana Hershey
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

5.  A novel mechanism by which interferon-gamma can regulate interleukin (IL)-13 responses. Evidence for intracellular stores of IL-13 receptor alpha -2 and their rapid mobilization by interferon-gamma.

Authors:  Michael O Daines; Gurjit K Khurana Hershey
Journal:  J Biol Chem       Date:  2002-01-10       Impact factor: 5.157

6.  IL13RA2 gene polymorphisms are associated with systemic sclerosis.

Authors:  Brigitte Granel; Yannick Allanore; Christophe Chevillard; Violaine Arnaud; Sandrine Marquet; Pierre-Jean Weiller; Jean-Marc Durand; Jean-Robert Harlé; Claire Grange; Yves Frances; Philippe Berbis; Jean Gaudart; Philippe de Micco; André Kahan; Alain Dessein
Journal:  J Rheumatol       Date:  2006-09-15       Impact factor: 4.666

7.  Localization of human interleukin 13 receptor in non-haematopoietic cells.

Authors:  M Akaiwa; B Yu; R Umeshita-Suyama; N Terada; H Suto; T Koga; K Arima; S Matsushita; H Saito; H Ogawa; M Furue; N Hamasaki; K Ohshima; K Izuhara
Journal:  Cytokine       Date:  2001-01-21       Impact factor: 3.861

8.  Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain.

Authors:  D Caput; P Laurent; M Kaghad; J M Lelias; S Lefort; N Vita; P Ferrara
Journal:  J Biol Chem       Date:  1996-07-12       Impact factor: 5.157

9.  Characterization of a novel human tumor antigen interleukin-13 receptor alpha2 chain.

Authors:  Koji Kawakami; Masaki Terabe; Mariko Kawakami; Jay A Berzofsky; Raj K Puri
Journal:  Cancer Res       Date:  2006-04-15       Impact factor: 12.701

10.  Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response.

Authors:  Monica G Chiaramonte; Margaret Mentink-Kane; Bruce A Jacobson; Allen W Cheever; Matthew J Whitters; Mary E P Goad; Anthony Wong; Mary Collins; Debra D Donaldson; Michael J Grusby; Thomas A Wynn
Journal:  J Exp Med       Date:  2003-03-17       Impact factor: 14.307

View more
  35 in total

Review 1.  The Role of Type 2 Inflammation in the Pathogenesis of Asthma Exacerbations.

Authors:  Eleanor M Dunican; John V Fahy
Journal:  Ann Am Thorac Soc       Date:  2015-11

2.  Inflammation-induced proteolytic processing of the SIRPα cytoplasmic ITIM in neutrophils propagates a proinflammatory state.

Authors:  Ke Zen; Yalan Guo; Zhen Bian; Zhiyuan Lv; Dihan Zhu; Hiroshi Ohnishi; Takashi Matozaki; Yuan Liu
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

3.  From the black widow spider to human behavior: Latrophilins, a relatively unknown class of G protein-coupled receptors, are implicated in psychiatric disorders.

Authors:  Ariel F Martinez; Maximilian Muenke; Mauricio Arcos-Burgos
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-11-12       Impact factor: 3.568

4.  Matrix metalloproteinase 8 contributes to solubilization of IL-13 receptor alpha2 in vivo.

Authors:  Weiguo Chen; Yasuhiro Tabata; Aaron M Gibson; Michael O Daines; Manoj R Warrier; Marsha Wills-Karp; Gurjit K Khurana Hershey
Journal:  J Allergy Clin Immunol       Date:  2008-08-09       Impact factor: 10.793

5.  TNF-α/IL-17 synergy inhibits IL-13 bioactivity via IL-13Rα2 induction.

Authors:  Vahe Badalyan; Robert Thompson; Kezia Addo; Lee A Borthwick; Andrew J Fisher; Tatiana Ort; Timothy G Myers; Thomas A Wynn; Thirumalai R Ramalingam
Journal:  J Allergy Clin Immunol       Date:  2014-06-20       Impact factor: 10.793

6.  IL-17A expression in HIV-specific CD8 T cells is regulated by IL-4/IL-13 following HIV-1 prime-boost immunization.

Authors:  Jayashree Ravichandran; Ronald J Jackson; Shubhanshi Trivedi; Charani Ranasinghe
Journal:  J Interferon Cytokine Res       Date:  2014-12-10       Impact factor: 2.607

Review 7.  Role of anti-inflammatory cytokines IL-4 and IL-13 in systemic sclerosis.

Authors:  Xiao-Lei Huang; Yu-Jie Wang; Jun-Wei Yan; Ya-Nan Wan; Bing Chen; Bao-Zhu Li; Guo-Jun Yang; Jing Wang
Journal:  Inflamm Res       Date:  2015-03-01       Impact factor: 4.575

8.  Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation.

Authors:  Larisa J Geskin; Sara Viragova; Donna B Stolz; Patrizia Fuschiotti
Journal:  Blood       Date:  2015-01-27       Impact factor: 22.113

Review 9.  The immune pathogenesis of scleroderma: context is everything.

Authors:  Matthew B Greenblatt; Antonios O Aliprantis
Journal:  Curr Rheumatol Rep       Date:  2013-01       Impact factor: 4.592

10.  IL-4 and IL-13 inhibit IL-1β and TNF-α induced kinin B1 and B2 receptors through a STAT6-dependent mechanism.

Authors:  P P C Souza; A B Brechter; R I Reis; C A S Costa; P Lundberg; U H Lerner
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.